PLRX (STOCKS)
Pliant Therapeutics, Inc. Common Stock
$1.300000
+0.020000 (+1.56%)
Prev close: $1.280000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Bernard Coulie
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $80.80M
- Employees
- 171
- P/E (TTM)
- -0.53
- P/B (TTM)
- 0.44
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
1
Buy
6
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.38 | $-0.39 | +0.0056 | +1.45% |
|
Sep 2025 (Q3)
|
$-0.43 | $-0.53 | +0.1042 | +19.51% |
|
Jun 2025 (Q2)
|
$-0.71 | $-0.71 | -0.0007 | -0.10% |
|
Mar 2025 (Q1)
|
$-0.92 | $-0.74 | -0.1812 | -24.53% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $156.37M |
| Research and Development | $109.16M |
| Other Operating Expenses | $47.22M |
| Operating Income/Loss | -$156.37M |
| Income/Loss From Continuing Operations After Tax | -$149.34M |
| Income/Loss From Continuing Operations Before Tax | -$149.34M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$149.34M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$149.34M |
| Net Income/Loss Available To Common Stockholders, Basic | -$149.34M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.43 |
| Diluted Earnings Per Share | -$2.43 |
| Basic Average Shares | 61,366,887 |
| Diluted Average Shares | 61,366,887 |
| Common Stock Dividends | $0.00 |
| Assets | $225.23M |
| Current Assets | $196.45M |
| Noncurrent Assets | $28.78M |
| Fixed Assets | $2.94M |
| Other Non-current Assets | $25.84M |
| Liabilities | $44.02M |
| Current Liabilities | $16.37M |
| Accounts Payable | $480.00K |
| Wages | $8.30M |
| Other Current Liabilities | $7.59M |
| Noncurrent Liabilities | $27.66M |
| Long-term Debt | $0.00 |
| Equity | $181.21M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $181.21M |
| Liabilities And Equity | $225.23M |
| Net Cash Flow From Operating Activities | -$128.34M |
| Net Cash Flow From Operating Activities, Continuing | -$128.34M |
| Net Cash Flow From Investing Activities | $134.29M |
| Net Cash Flow From Investing Activities, Continuing | $134.29M |
| Net Cash Flow From Financing Activities | -$31.70M |
| Net Cash Flow From Financing Activities, Continuing | -$31.70M |
| Net Cash Flow | -$25.74M |
| Net Cash Flow, Continuing | -$25.74M |
| Comprehensive Income/Loss | -$149.68M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$149.68M |
| Other Comprehensive Income/Loss | -$149.68M |
| Other Comprehensive Income/Loss Attributable To Parent | -$336.00K |